RNAM NASDAQ
Avidity Biosciences Inc
1W: -1.9%
1M: -1.7%
YTD: -1.8%
$72.86
Last traded 2026-03-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2025-08-07
Earliest Filing
2026-02-27
Latest Filing
acquirer: 4
partner: 3
supplier: 2
Counterparties (Filed by RNAM)
9 relationshipsCompanies named in RNAM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Novartis AG | NVSEF | acquirer | Parent company acquiring Avidity Biosciences, Inc. via merger | 2026-02-27 | View |
| Ajax Acquisition Sub, Inc. | — | acquirer | Merger subsidiary of Novartis AG used to acquire Avidity Biosciences, Inc. | 2026-02-27 | View |
| Bristol-Myers Squibb Company | — | partner | Counterparty to collaboration agreements retained by SpinCo | 2026-02-27 | View |
| Eli Lilly and Company | LLY | partner | Counterparty to collaboration agreements retained by SpinCo | 2026-02-27 | View |
| Novartis AG | NVSEF | acquirer | Parent company acquiring Avidity Biosciences, Inc. in a merger transaction. | 2025-10-27 | View |
| Ajax Acquisition Sub, Inc. | — | acquirer | Wholly owned subsidiary of Novartis AG used as the merger vehicle. | 2025-10-27 | View |
| Bryce Therapeutics, Inc. | — | partner | Newly formed spin-off entity (SpinCo) created to hold specific assets and liabilities. | 2025-10-27 | View |
| Lonza LTD | — | supplier | Manufacturing Services Agreement for drug substance and drug product | 2025-08-07 | View |
| Lonza Sales LTD | — | supplier | Manufacturing Services Agreement for drug substance and drug product | 2025-08-07 | View |
Recent 8-K Filings (4)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-02-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-07-23 | Other Events | View | |
| 2025-06-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-29 | Changes in Registrant's Certifying Accountant | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR